Cancer Immunotherapy for Gliomas: Overview and Future Directions

Immunotherapy has been highlighted because we have obtained much evidence, which includes theoretical backborn as well as favorable results from clinical trials. As immunotherapy gives an apparently different cytotoxic mechanism and a little adverse event, the promising results are getting a lot of...

Descripción completa

Detalles Bibliográficos
Autor principal: HASHIMOTO, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945593/
https://www.ncbi.nlm.nih.gov/pubmed/27087194
http://dx.doi.org/10.2176/nmc.ra.2015-0310
Descripción
Sumario:Immunotherapy has been highlighted because we have obtained much evidence, which includes theoretical backborn as well as favorable results from clinical trials. As immunotherapy gives an apparently different cytotoxic mechanism and a little adverse event, the promising results are getting a lot of attention. In this article, cancer immunotherapy for gliomas is reviewed thoroughly from the literature, focusing on the clinical trial results.

Ejemplares similares